Company Directory

Battelle, one of the world’s largest independent, non-profit R&D organisations, focuses its contract research efforts on three areas: health, national security & environment. Its involvement in drug delivery goes back to the 1990s – main areas of focus are: injectors, patch pumps and inhalation. 

Baumann Group manufacturers springs and stampings and has a dedicated, ISO13485-certified medical division to addresses the unique needs of the medical and pharmaceutical industry.  The division designs and manufactures springs for drug delivery devices such as syringes, autoinjectors and inhalers.

BioPharma Solutions, a business unit of Baxter, provides contract manufacturing form/fill/finish for injectables. The company has >85 years of experience and offers sterile dosage forms including prefilled syringes, liquid vials, lyophilised vials, cartridges, and diluents for reconstitution.

BD is a large, diverse, global medical technology company. Its Medical-Pharmaceutical Systems division is the world's largest syringe manufacturer. It offers prefillable syringes, self-injection systems, safety and shielding solutions, and needle technologies and associated pharma services.

Berry Global Healthcare, a division of non-woven, rigid, and flexible products company Berry Global, offers a wide number of specialisations in drug administration, including oral, nasal, pulmonary and ophthalmic, as well as an extensive range of pharmaceutical packaging.

Bespak is a global CDMO focused on inhaled and nasal drug delivery devices and drug-device combination products. The company’s service offering spans early-stage feasibility, analytical services, and product development.

Bexson Biomedical is developing ketamine for pain management and mental health disorders, and applying a proprietary delivery system to several psychedelic and non-psychedelic compounds. In 2020, it partnered with Stevanato for the development of ketamine in a wearable subcutaneous injector.

Beyond Air is developing a nitric oxide (NO) generator and drug delivery system, LungFit™ that uses NO generated from ambient air to deliver precise amounts of NO to the lungs for the potential treatment of a variety of pulmonary diseases. The LungFit™ delivery system can generate up to 400 ppm of NO.

Biocorp is an expert in connectivity but develops and manufactures both connected and non-connected injectable drug delivery devices. In addition to its own connected delivery devices it also offers add-ons for existing respiratory and parenteral drug delivery systems.